1. Jha, V. et al. Chronic kidney disease: Global dimension and perspectives. Lancet 382, 260–272 (2013).
2. Sherwood, M. & Mccullough, P. A. Chronic kidney disease from screening, detection, and awareness, to prevention. Lancet Glob. Health 4, e288–e289 (2016).
3. Imai, E. et al. Prevalence of chronic kidney disease in the Japanese general population. Clin. Exp. Nephrol. 13, 621–630 (2009).
4. Muntner, P., He, J., Hamm, L., Loria, C. & Whelton, P. K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J. Am. Soc. Nephrol. 13, 745–753 (2002).
5. Anavekar, N. S. et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med.351, 1285–1295 (2004).
6. Weiner, D. E. et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J. Am. Soc. Nephrol. 15, 1307–1315 (2004).
7. Ninomiya, T. et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study.Kidney Int. 68, 228–236 (2005).
8. Irie, F. et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 69, 1264–1271 (2006).
9. De Francisco, A. L. M., Fresnedo, G. F., Palomar, R., Piñera, C. & Arias, M. The renal benefits of a healthy lifestyle. Kidney Int. 68, 2–6 (2005).
10. Kelly, J. T. et al. Modifiable lifestyle factors for primary prevention of CKD: A systematic review and meta-analysis. J. Am. Soc. Nephrol 32, 239–253 (2021).
11. Yamagata, K. et al. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int. 71, 159–166 (2007).
12. Uehara, S. et al. Relationship between alcohol drinking pattern and risk of proteinuria: The Kansai Healthcare Study. J. Epidemiol.26, 464–470 (2016).
13. Kimura, Y. et al. Alcohol consumption and incidence of proteinuria: A retrospective cohort study. Clin. Exp. Nephrol. 22, 1133–1142 (2018).
14. Okubo, Y. et al. Association of alcohol consumption with incident hypertension among middle-aged and older Japanese popula- tion: The Ibarakai prefectural health study (IPHS). Hypertension 63, 41–47 (2014).
15. Roerecke, M. et al. The effect of a reduction in alcohol consumption on blood pressure: A systematic review and meta-analysis.Lancet Public Health. 2, e108–e120 (2017).
16. Taylor, B. et al. Alcohol and hypertension: Gender differences in dose-response relationships determined through systematic review and meta-analysis: REVIEW. Addiction 104, 1981–1990 (2009).
17. Heianza, Y. et al. Role of alcohol drinking pattern in type 2 diabetes in Japanese men: The Toranomon Hospital Health Manage- ment Center Study 11 (TOPICS 11). Am. J. Clin. Nutr. 97, 561–568 (2013).
18. Wakabayashi, I. Light-to-moderate alcohol drinking reduces the impact of obesity on the risk of diabetes mellitus. J. Stud. Alcohol Drugs 75, 1032–1038 (2014).
19. Nishigaki, D. et al. Body mass index modifies the association between frequency of alcohol consumption and incidence of hyper- tension in men but not in women: A retrospective cohort study. Hypertens. Res. 43, 322–330 (2020).
20. Waki, K. et al. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: A population- based prospective study in the JPHC study cohort 1. Diabet. Med. 22, 323–331 (2005).
21. Park, M., Lee, S. M. & Yoon, H. J. Association between alcohol intake and measures of incident CKD: An analysis of nationwide health screening data. PLoS ONE 14, 1–13 (2019).
22. Schaeffner, E. S. et al. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch. Intern. Med. 165, 1048–1053 (2005).
23. Koning, S. H. et al. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int.87, 1009–1016 (2015).
24. Perneger, T. V, Whelton, P. K., Puddey, I. B. & Klag, M. J. Risk of end-stage renal disease associated with alcohol consumption.Am. J. Epidemiol. 150, 1275–81. (1999).
25. Shankar, A., Klein, R. & Klein, B. E. K. The association among smoking, heavy drinking, and chronic kidney disease. Am. J. Epi- demiol. 164, 263–271 (2006).
26. Huang, Y. et al. Moderate alcohol consumption and atherosclerosis: Meta-analysis of effects on lipids and inflammation. Wien. Klin. Wochenschr. 129, 835–843 (2017).
27. McCarthy, E. T. et al. Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE. Prostaglandins Other Lipid Mediat. 116–117, 88–98 (2015).
28. Davies, M. J. et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: A randomized controlled trial. J. Am. Med. Assoc. 287, 2559–2562 (2002).
29. Paulson, Q. X., Hong, J., Holcomb, V. B. & Nunez, N. P. Effects of body weight and alcohol consumption on insulin sensitivity. Nutr. J. 9, 1–14 (2010).
30. Welsh, G. I. et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329–340 (2010).
31. Kiechl, S. et al. Alcohol consumption and atherosclerosis: What is the relation?: Prospective results from the Bruneck Study. Stroke 29, 900–907 (1998).
32. Rocco, A., Compare, D., Angrisani, D., Sanduzzi Zamparelli, M. & Nardone, G. Alcoholic disease: Liver and beyond. World J. Gastroenterol. 20, 14652–14659 (2014).
33. Janicko, M., Veseliny, E., Senajova, G. & Jarcuska, P. Predictors of hepatorenal syndrome in alcoholic liver cirrhosis. Biomed. Pap.159, 661–665 (2015).
34. Min Qi Wang, Nicholson, M. E., Jones, C. S., Fitzhugh, E. C. & Westerfield, C. R. Acute alcohol intoxication, body composition, and pharmacokinetics. Pharmacol. Biochem. Behav. 43, 641–643 (1992).
35. Maudens, K. E. et al. The influence of the body mass index (BMI) on the volume of distribution of ethanol. Forensic Sci. Int. 243, 74–78 (2014).
36. Matoba, N. et al. GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits. Nat. Hum. Behav. 4, 308–316 (2020).
37. Shaper, A. G., Wannamethee, G. & Walker, M. Alcohol and mortality in British men: Explaining the U-shaped curve. Lancet 332, 1267–1273 (1988).
38. Jonathan, E. R. & Derrick, B. A. Effect of alcohol on risk of coronary heart disease and stroke: Causality, bias, or a bit of both?.Vasc. Health Risk Manag. 2, 239–249 (2016).
39. Sato, K. K. et al. Drinking pattern and risk of chronic kidney disease: the kansai healthcare study. Am. J. Nephrol. 40, 516–522 (2014).
40. White, S. L. et al. Alcohol consumption and 5-year onset of chronic kidney disease: The AusDiab study. Nephrol. Dial. Transpl. 24, 2464–2472 (2009).
41. Pan, C. S. et al. Alcohol use disorder tied to development of chronic kidney disease: A nationwide database analysis. PLoS ONE 13, 1–13 (2018).
42. Goedde, H. W. et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum. Genet. 88, 344–346 (1992).
43. Matsuo, K. et al. Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehy- drogenase 2 Glu487Lys polymorphism: Analysis of 2,299 Japanese subjects. Cancer Epidemiol. Biomarkers Prev. 15, 1009–1013 (2006).
44. Britton, A., Ben-Shlomo, Y., Benzeval, M., Kuh, D. & Bell, S. Life course trajectories of alcohol consumption in the United Kingdom using longitudinal data from nine cohort studies. BMC Med. 13, 1–9 (2015).
45. Use, S., Database, N., Claims, H. I. & Checkups, S. H. The 4th NDB Open Data. MHLW Japan. https://www.mhlw.go.jp/english/ index.html (2017).
46. Nagakura, Y., Kato, H., Asano, S., Jinno, Y. & Tanei, S. The significant association between health examination results and popula- tion health: A cross-sectional ecological study using a nation-wide health checkup database in Japan. Int. J. Environ. Res. Public Health 18, 836 (2021).
47. Guo, R. & Jun, R. Alcohol and acetaldehyde in public health: From marvel to menace. Int. J. Environ. Res. Public Health 7, 1285–1301 (2010).
48. Levin, A. & Stevens, P. E. Summary of KDIGO 2012 CKD Guideline: Behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 85, 49–61 (2014).
49. Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982–992 (2009).
50. Umemura, S. et al. The japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens. Res. 42, 1235–1481 (2019).
51. Seino, Y. et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J. Diabetes Investig. 1, 212–228 (2010).
52. Teramoto, T. et al. Diagnosis of atherosclerosis. J. Atheroscler. Thromb. 21, 296–298 (2014).